Lead Capture for Pharma That Stops Two Managers Promising One District

A franchise enquirer wants a territory and wants an answer today. A stockist wants credit terms and a scheme. An institutional buyer moves on a tender calendar measured in quarters. A field representative generates coverage that is not a lead at all until a chemist actually places an order. Most companies pour all four into one enquiry list, then wonder why the pipeline never reconciles with the order book. The first decision in pharma lead capture is not which fields to collect, it is which stream this enquiry belongs to, because everything downstream depends on that answer.

Franchise enquiries are territory questions in disguise

Almost every PCD enquiry is really a single question: is my district available. If the answer lives in a manager's head or in an old spreadsheet, two managers will give two answers and the company will honour neither cleanly. Structured territory fields make availability a search rather than a recollection, and they turn allocation into a deliberate commercial decision about coverage rather than a race between whoever replied first.

Franchise enquiry volume is high and its quality is uneven. A party with a valid drug licence, a functioning counter and a stated monthly requirement is a business conversation. A party with none of those is an ambition, and treating both identically is how commercial teams lose their month. Capturing licence, GST, trade experience and expected offtake at first contact lets the team answer everyone quickly and then spend its real attention on the parties who can actually trade, which is also fairer to the enquirers who cannot.

Representative coverage is the most under-used lead source in pharma. A visit that produces a chemist asking about a new division, or a hospital purchase officer requesting a rate list, is a genuine opportunity that typically survives only as a line in a notebook. Mobile capture at the counter, working offline where the network does not, moves that information into the pipeline while it is still current, and lets the zonal manager act during the same week rather than reading about it at month end.

It will not verify a licence for you, interpret a regulation, or approve any content. Compliance, product claims and prescriber-facing material stay exactly where they are, with the people accountable for them. It will not improve portal enquiry quality either. What it removes is the avoidable damage: the double-promised territory, the enquiry nobody owned, the field visit nobody read, and the month-end pipeline that nobody believes.

More on this: CRM dialer, sales automation, lead management software, CRM vs Excel, WhatsApp CRM, and India pricing.